Certuity LLC Grows Position in Lam Research Co. (NASDAQ:LRCX)

Certuity LLC lifted its stake in Lam Research Co. (NASDAQ:LRCX) by 106.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,693 shares of the semiconductor company’s stock after buying an additional 872 shares during the quarter. Certuity LLC’s holdings in Lam Research were worth $1,326,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the business. Orion Capital Management LLC acquired a new position in Lam Research in the third quarter worth approximately $25,000. BluePath Capital Management LLC bought a new stake in shares of Lam Research during the 3rd quarter valued at approximately $28,000. OFI Invest Asset Management acquired a new position in shares of Lam Research during the 3rd quarter valued at $30,000. Asset Dedication LLC boosted its holdings in shares of Lam Research by 56.7% in the 3rd quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock worth $30,000 after buying an additional 17 shares during the last quarter. Finally, Valued Wealth Advisors LLC bought a new position in Lam Research during the fourth quarter valued at approximately $30,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Trading Down 2.9 %

LRCX traded down $26.66 during trading hours on Tuesday, reaching $902.15. The company’s stock had a trading volume of 396,397 shares, compared to its average volume of 1,064,956. Lam Research Co. has a fifty-two week low of $507.19 and a fifty-two week high of $1,007.39. The business’s 50-day moving average is $943.72 and its 200-day moving average is $813.44. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.82 and a quick ratio of 1.84. The stock has a market cap of $118.27 billion, a PE ratio of 34.16, a P/E/G ratio of 2.88 and a beta of 1.51.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, April 24th. The semiconductor company reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.26 by $0.53. Lam Research had a net margin of 25.35% and a return on equity of 45.96%. The company had revenue of $3.79 billion for the quarter, compared to analyst estimates of $3.72 billion. During the same quarter last year, the business earned $6.99 EPS. Lam Research’s revenue for the quarter was down 2.0% on a year-over-year basis. As a group, equities research analysts predict that Lam Research Co. will post 29.54 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 3rd. Shareholders of record on Wednesday, March 13th were given a $2.00 dividend. The ex-dividend date was Tuesday, March 12th. This represents a $8.00 dividend on an annualized basis and a yield of 0.89%. Lam Research’s dividend payout ratio (DPR) is presently 29.42%.

Insider Buying and Selling

In related news, SVP Seshasayee Varadarajan sold 5,500 shares of the firm’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the transaction, the senior vice president now directly owns 22,095 shares of the company’s stock, valued at $20,380,648.95. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Abhijit Y. Talwalkar sold 882 shares of the company’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $972.03, for a total transaction of $857,330.46. Following the completion of the sale, the director now owns 10,541 shares in the company, valued at $10,246,168.23. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Seshasayee Varadarajan sold 5,500 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $922.41, for a total value of $5,073,255.00. Following the completion of the sale, the senior vice president now owns 22,095 shares in the company, valued at $20,380,648.95. The disclosure for this sale can be found here. Insiders sold a total of 7,089 shares of company stock valued at $6,614,781 over the last ninety days. Insiders own 0.32% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on LRCX shares. Needham & Company LLC restated a “buy” rating and issued a $1,030.00 price target on shares of Lam Research in a research note on Thursday, April 25th. UBS Group raised their price target on Lam Research from $1,130.00 to $1,150.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Barclays raised their price target on Lam Research from $825.00 to $865.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 25th. B. Riley raised Lam Research from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $870.00 to $1,100.00 in a report on Friday, April 19th. Finally, StockNews.com upgraded Lam Research from a “hold” rating to a “buy” rating in a report on Friday. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and an average target price of $950.85.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.